Jenny
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
About Jenny
Jenny is recorded as Analyst at Leerink Partners. Jenny has spoken on 2 earnings calls across 2 companies, most recently for Ptc Therapeutics, Inc. on April 28, 2026. Those appearances were for Ptc Therapeutics, Inc. (PTCT) and Biomarin Pharmaceutical Inc (BMRN). The companies whose calls Jenny spoke on are classified in the Healthcare sector.
Jenny on recent calls
“With oral genotypes, independent SLC approaches now in late-stage trials, how are you thinking about the parts of the PKU market where suffiance is most defensible long-term?”
“I think for previously, you guys have mentioned that Voxoco has penetrated just under 20% of the market in achondroplasia as of the second quarter last year. Can you talk a little bit more about what strategies you're implementing to drive further adoption among patients?”
Affiliation history
-
Leerink Partners
Analyst
Transcript header (unverified)
Current